Looking beyond current treatments for Central Nervous System (CNS) diseases and disorders with high unmet need
VistaGen Therapeutics (NASDAQ: VTGN) is a clinical-stage biopharmaceutical company developing new generation medicines for CNS diseases and disorders for which current treatments fall short of patient needs, including depression and social anxiety disorder.
Our CNS pipeline is focused on drug candidates with potential for convenient, at-home use, rapid-onset therapeutic benefits, and exceptional safety.
Our CNS Pipeline